Know Cancer

or
forgot password

    • cancer clinical trials in oregon city, OR

    • S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Willamette Falls Hospital
    Oregon City, Oregon 97045
    Breast Cancer
    Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
    GSK Investigational Site
    Oregon City, Oregon 97045
    Prophylaxis for HPV Infections and Associated Cervical Neoplasia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Providence Willamette Falls Medical Center
    Oregon City, Oregon 97045
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer
    GSK Investigational Site
    Oregon City, Oregon 97045
    Lung Cancer, Non-Small Cell
    GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
    GSK Investigational Site
    Oregon City, Oregon 97045
    Lung Cancer, Non-Small Cell
    ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
    GSK Investigational Site
    Oregon City, Oregon 97045
    Neoplasms, Breast, Breast Cancer
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Providence Willamette Falls Medical Center
    Oregon City, Oregon 97045
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Willamette Falls Community Hospital
    Oregon City, Oregon 97045
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Providence Willamette Falls Medical Center
    Oregon City, Oregon 97045
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Providence Willamette Falls Medical Center
    Oregon City, Oregon 97045
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Providence Willamette Falls Medical Center
    Oregon City, Oregon 97045
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
    GSK Investigational Site
    Oregon City, Oregon 97045
    Neoplasms, Breast
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Willamette Falls Hospital
    Oregon City, Oregon 97045
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma
    GSK Investigational Site
    Oregon City, Oregon 97045
    Carcinoma, Renal Cell
    S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
    Willamette Falls Hospital
    Oregon City, Oregon 97045
    Malignant Mesothelioma
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Providence Willamette Falls Medical Center
    Oregon City, Oregon 97045
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Willamette Falls Hospital
    Oregon City, Oregon 97045
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Willamette Falls Community Hospital
    Oregon City, Oregon 97045
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Treatment With Pazopanib for Neoadjuvant Breast Cancer
    GSK Investigational Site
    Oregon City, Oregon 97045
    Neoplasms, Breast
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Willamette Falls Hospital
    Oregon City, Oregon 97045
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Willamette Falls Hospital
    Oregon City, Oregon 97045
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Willamette Falls Hospital
    Oregon City, Oregon 97045
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
    GSK Investigational Site
    Oregon City, Oregon 97045
    Leukemia-relapsed or Refractory, Cancer
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Willamette Falls Hospital
    Oregon City, Oregon 97045
    Colorectal Cancer, Precancerous Condition
    S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
    Willamette Falls Hospital
    Oregon City, Oregon 97045
    brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
    GSK Investigational Site
    Oregon City, Oregon 97045
    Thrombocytopaenia
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Providence Willamette Falls Medical Center
    Oregon City, Oregon 97045
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Providence Willamette Falls Medical Center
    Oregon City, Oregon 97045
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
    Willamette Falls Hospital
    Oregon City, Oregon 97045
    Breast Cancer, Depression, Fatigue, Sleep Disorders
    An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer
    GSK Investigational Site
    Oregon City, Oregon 97045
    Lung Cancer, Non-Small Cell
    Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
    Providence Willamette Falls Medical Center
    Oregon City, Oregon 97045
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Providence Willamette Falls Medical Center
    Oregon City, Oregon 97045
    Breast Cancer
    A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
    GSK Investigational Site
    Oregon City, Oregon 97045
    Non-Small-Cell Lung Cancer, Lung Cancer, Non-Small Cell
    Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
    GSK Investigational Site
    Oregon City, Oregon 97045
    Constipation, Bowel Dysfunction
    Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18
    GSK Investigational Site
    Oregon City, Oregon 97045
    Human Papillomavirus (HPV) Infection, Cervical Neoplasia
    Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
    GSK Investigational Site
    Oregon City, Oregon 97045
    Neoplasms, Prostate, Prostate Cancer
    Brain Metastases In ErbB2-Positive Breast Cancer
    GSK Investigational Site
    Oregon City, Oregon 97045
    Neoplasms, Breast
    Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects
    GSK Investigational Site
    Oregon City, Oregon 97045
    Neoplasms, Breast
    Study of GSK1363089 in Metastatic Gastric Cancer
    GSK Investigational Site
    Oregon City, Oregon 97045
    Neoplasms, Gastrointestinal Tract
    Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US
    GSK Investigational Site
    Oregon City, Oregon 97045
    Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
    S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
    Willamette Falls Hospital
    Oregon City, Oregon 97045
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Willamette Falls Hospital
    Oregon City, Oregon 97045
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
    Providence Willamette Falls Medical Center
    Oregon City, Oregon 97045
    Light Chain Deposition Disease, Primary Systemic Amyloidosis
    Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
    Willamette Falls Hospital
    Oregon City, Oregon 97045
    Breast Cancer